iTeos Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.147; its P/E ratio is -3.28; iTeos Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	$ 343.00K	$ 53.91M
Gross Profit	-	-	-	$ 343.00K	$ -192.56M
EBIT	$ -28.19M	$ -33.42M	$ -33.07M	$ -14.35M	$ 10.21M
EBITDA	$ -27.96M	$ -33.20M	$ -32.84M	$ -14.13M	$ 9.81M
Net Income Common Stockholders	$ -30.55M	$ -33.29M	$ -34.30M	$ -15.55M	$ 20.45M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 531.92M	$ 599.03M	$ 599.22M	$ 602.14M	$ 613.16M
Total Assets	$ 667.59M	$ 677.64M	$ 703.75M	$ 728.35M	$ 754.99M
Total Debt	$ 6.06M	$ 5.93M	$ 5.45M	$ 4.63M	$ 4.67M
Net Debt	$ -525.86M	$ -593.10M	$ -593.78M	$ -597.51M	$ -608.49M
Total Liabilities	$ 92.36M	$ 79.38M	$ 80.22M	$ 76.08M	$ 91.66M
Stockholders Equity	$ 575.23M	$ 598.26M	$ 623.53M	$ 652.26M	$ 663.33M
Cash Flow	-
Free Cash Flow	$ -15.18M	$ -34.72M	$ -30.25M	$ -26.67M	$ -27.29M
Operating Cash Flow	$ -13.77M	$ -33.89M	$ -29.55M	$ -26.55M	$ -27.17M
Investing Cash Flow	$ 61.56M	$ 22.69M	$ 20.10M	$ -31.69M	$ -445.12M
Financing Cash Flow	$ 307.00K	$ 10.00K	$ 218.00K	$ 578.00K	$ 1.37M

Currency in USD

iTeos Therapeutics Earnings and Revenue History

Income Statement >

iTeos Therapeutics Debt to Assets

Balance Sheet >

iTeos Therapeutics Cash Flow

Cash Flow >

iTeos Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing